
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SSRP1 CRISPR/Cas9 KO Plasmid (h) | sc-401780 | 20 µg | $397.00 |
SSRP1 (structure specific recognition protein 1) is an essential subunit of the FACT chromatin remodeling complex that facilitates nucleosome disassembly and reassembly during transcription, DNA replication, and DNA repair. By coordinating histone chaperone activity with RNA polymerase II progression and replication fork dynamics, SSRP1 helps maintain genome stability and regulates chromatin accessibility. SSRP1-dependent processes intersect with cell-cycle control, DNA damage responses, and epigenetic regulation, making it relevant to studies of replication stress and aberrant transcriptional programs. Dysregulated FACT/SSRP1 activity has been implicated in oncogenic chromatin states and altered proliferative capacity, supporting its use as a mechanistic node in cancer biology and genome maintenance research.
SSRP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SSRP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SSRP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SSRP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SSRP1 protein expression.
This CRISPR knockout system enables efficient generation of SSRP1-deficient cell models for investigation of SSRP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.